Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea - Wikidata - awgldk - TriplyDB

Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea

Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea

http://www.wikidata.org/entity/Q34093606

about

A cancer specific cell-penetrating peptide, BR2, for the efficient delivery of an scFv into cancer cells The Zinc-Schiff Base-Novicidin Complex as a Potential Prostate Cancer Therapy Gene delivery to cornea.Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin.Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.Probing potassium channel function in vivo by intracellular delivery of antibodies in a rat model of retinal neurodegeneration.A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo.The potential of nanomedicine therapies to treat neovascular disease in the retina.POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides.Cell-penetrating peptide-functionalized quantum dots for intracellular delivery.Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy Vector platforms for gene therapy of inherited retinopathies.Conjugation of cell-penetrating peptides with poly(lactic-co-glycolic acid)-polyethylene glycol nanoparticles improves ocular drug delivery Extended duration of transgene expression from pegylated POD nanoparticles enables attenuation of photoreceptor degeneration.Noninvasive routes of proteins and peptides drug delivery.Delivery of Quantum Dot-siRNA Nanoplexes in SK-N-SH Cells for BACE1 Gene Silencing and Intracellular Imaging.CPP2-p16MIS treatment-induced colon carcinoma cell death in vitro and prolonged lifespan of tumor-bearing mice.Topical ocular delivery to laser-induced choroidal neovascularization by dual internalizing RGD and TAT peptide-modified nanoparticles Nanoparticle-motivated gene delivery for ophthalmic application Corneal Penetrating Elastin-Like Polypeptide Carriers.Intracellular delivery of proteins into mouse Müller glia cells in vitro and in vivo using Pep-1 transfection reagent Barriers for retinal gene therapy: separating fact from fiction.Cell-penetrating peptide TAT-mediated delivery of acidic FGF to retina and protection against ischemia-reperfusion injury in rats.Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Secretory TAT-peptide-mediated protein transduction of LIF receptor α-chain distal cytoplasmic motifs into human myeloid HL-60 cells.G-quartet oligonucleotide mediated delivery of proteins into photoreceptors and retinal pigment epithelium via intravitreal injection.Nanoparticles for retinal gene therapy.Nano-vectors for the Ocular Delivery of Nucleic Acid-based Therapeutics.Cell-penetrating peptides for the delivery of nucleic acids.Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers.Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma.Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.Delivery of RNAi therapeutics: work in progress.Non-Viral Delivery and Therapeutic Application of Small Interfering RNAs.Delivering the promise of small ncRNA therapeutics.Peptide-mediated delivery: an overview of pathways for efficient internalization.Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.Strategies to stabilize cell penetrating peptides for in vivo applications.Hydrophobic and electrostatic interactions between cell penetrating peptides and plasmid DNA are important for stable non-covalent complexation and intracellular delivery.

P2860

Q28533791-4777DDCF-A68F-41E1-ACA2-1EA4FB86C84C Q28554619-F7F1B16B-6563-4B4E-9D77-3037E0302E8A Q30476991-63635557-DD28-4BCF-8987-0DE58ADA23AA Q33732512-F1254D77-C6A5-4344-850C-B0B091C53B6B Q33849404-F770333C-31C4-4E27-A340-E4A2126506FD Q34005054-F328B8EA-0526-450A-A8A5-26BA74ADB93C Q34093683-007408D8-9DCE-4C3E-B94C-9DEF5D42C255 Q34220590-448E03CB-830F-49B0-BF02-300AEC689879 Q34343753-65311FCB-A713-4BD3-BE3D-6BC705755113 Q34392754-9FC15065-6D8A-444F-B7BC-CB68133E04AA Q34392762-F1F1F7B4-44B8-4D61-9BAF-D53C51BA756B Q34546382-FB57D5B8-BC1E-4A1C-AEE6-2D35AD9B271B Q34561531-F40DE266-2438-49BE-9AA9-C6B427D1C114 Q35043797-C72689A0-A93A-483D-ABB7-A5CB6E87F914 Q35054149-9686D255-6B22-4B9A-A6D2-2A652566DDDD Q36029817-0C73AC09-317D-48EE-A9DD-7ACEC3742433 Q36053948-C31CEB6B-8658-41AC-8672-3EF62A4B720F Q36093248-D143F457-31DA-4FAD-ACD2-0650585E776D Q36297619-703C649B-5E77-476A-AEAB-7B81142B2D5D Q36396201-D7149300-13F2-44DC-8DCC-D8099FCD73F0 Q37081322-CD4F583E-BC0A-489A-8042-DB9E812BB969 Q37189701-F69AFE6B-7CE6-4F33-816F-7A0F552DCDE9 Q37195446-03B85440-024E-463E-B675-E77AEE6D866D Q37295720-826E6C1A-51D5-42FB-9BD8-CFBB33F9F7BB Q37347451-1E34CE84-113F-4ACA-ABE8-E92438A2E0FB Q37370855-6956273D-3CB0-4986-A347-307740959820 Q37677464-44274796-637D-4279-8B52-21260DA6B5CA Q37746102-72E6772D-84FB-4A55-97CF-83275B6CBF2E Q37942156-4EA4B900-A1EE-4072-AF42-0BBE02B7384F Q38010767-44385EE8-BE0C-4706-91AA-6E9A4993D9D0 Q38017713-13D56D91-DBBB-473F-95F8-1F5CBCE0A75F Q38030642-0ECE594C-5308-453C-9C19-5EB0ABFC14CA Q38128390-01EF82A7-4578-4370-A090-76BF6FF5EC00 Q38160246-6FEEDD52-1E39-4031-811E-EACA0D365D3A Q38168518-D2438D2B-5ACF-44A4-9A42-BC9B775DB18C Q38226666-55363F41-A956-4AD2-836E-6E4039341012 Q38285852-D2875C1D-3EDB-4662-BC60-1579881E2831 Q38573732-92263277-B095-42C6-B753-17C031F45865 Q38602460-25832FF3-1E0D-4E85-97B1-B8429E6AA9BD Q38741797-D16D8355-7D56-4C11-BF36-6E4C978F5018

P2860

Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea

http://www.wikidata.org/entity/Q34093606

description

2007 nî lūn-bûn

@nan

2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Cell-penetrating peptide for e ...... es including retina and cornea

@ast

Cell-penetrating peptide for e ...... es including retina and cornea

@en

Cell-penetrating peptide for e ...... es including retina and cornea

@nl

type

label

Cell-penetrating peptide for e ...... es including retina and cornea

@ast

Cell-penetrating peptide for e ...... es including retina and cornea

@en

Cell-penetrating peptide for e ...... es including retina and cornea

@nl

prefLabel

Cell-penetrating peptide for e ...... es including retina and cornea

@ast

Cell-penetrating peptide for e ...... es including retina and cornea

@en

Cell-penetrating peptide for e ...... es including retina and cornea

@nl

P1433

Q34093606-E303052A-0903-44B5-A283-32B8038E1782

P1476

Q34093606-0DAE2D5E-35B5-4D28-8ED8-895A7D78C2BF

P2093

Q34093606-268349AB-248C-45B6-A4E7-8976445D5F0A

Q34093606-7B7FC4D2-EE9B-4381-B6F3-BDC9F7E4B8A2

Q34093606-E8730056-CCF4-49CB-BD61-FA9673C52EB4

P2860

Q34093606-257570CF-73EF-46CF-B4CC-8B983068DD83

Q34093606-2D16E7A0-5988-4560-BDD5-496CB3EDBA37

Q34093606-3E7D92E4-962B-458A-AE4A-6E877ADB9D14

Q34093606-40885721-A150-40DB-92F7-CBB75A472D75

Q34093606-427AAF5B-D7DA-486A-B8B9-ADEBA8C273C3

Q34093606-50374ADC-27F0-4018-BB3C-7D881C9C0908

Q34093606-5072016C-D890-4098-A5F8-FCF88D77A8D5

Q34093606-5B139738-139A-4503-BFA1-05BB23660DD4

Q34093606-762D6AEF-F4C0-4016-A510-CA49A8AE7A1D

Q34093606-76AC215D-99A0-4266-B1D6-2C5C170487B2

P304

Q34093606-00086C09-652B-4808-8D9A-E7B1E1E743E7

P31

Q34093606-31B45721-2711-471F-B9DF-19272F497E72

P356

Q34093606-3CF78116-FD1F-4793-898A-5CE62708CC75

P433

Q34093606-A04EE6BF-4B55-4D3E-81E7-9019A9C60158

P478

Q34093606-4E128936-0242-444B-A3CD-FA3524255C6D

P577

Q34093606-3ED8A9C4-0736-415B-8CE0-6699FCDD6ADD

P5875

Q34093606-5ACF85F8-791C-4A36-B2CC-982027F938CB

P698

Q34093606-EC581769-F8F9-482A-B9C8-A8E87E4574D9

P932

Q34093606-C2AD1652-6706-42C4-B09D-B90C0A6F1FBD

P356

P1433

Molecular Therapy

P1476

Cell-penetrating peptide for e ...... es including retina and cornea

@en

P2093

Leslie N Johnson

http://www.w3.org/2001/XMLSchema#string

Rajendra Kumar-Singh

http://www.w3.org/2001/XMLSchema#string

Siobhan M Cashman

http://www.w3.org/2001/XMLSchema#string

P2860

Acidic and basic fibroblast growth factor messenger RNA and protein show increased expression in adult compared to developing normal and dystrophic rat retina

Retinitis pigmentosa

Cellular uptake of the tat protein from human immunodeficiency virus

Macular degeneration: recent advances and therapeutic opportunities.

The third helix of the Antennapedia homeodomain translocates through biological membranes.

Delivery of bioactive molecules into the cell: the Trojan horse approach.

Centennial review of corneal transplantation.

Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease.

Endogenous bacterial endophthalmitis: a 17-year prospective series and review of 267 reported cases.

Promising new treatments for neovascular age-related macular degeneration.

P304

107-114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.MT.6300324

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2007-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5920891

http://www.w3.org/2001/XMLSchema#string

P698

17923842

http://www.w3.org/2001/XMLSchema#string

P932

4145720

http://www.w3.org/2001/XMLSchema#string